GSK is paying $80 million to ink a multi-target neurodegenerative pact with Flagship-founded Vesalius Therapeutics that ...

Plus: How AI can make it easier to find drugs from nature and a study suggests Ozempic could treat alcoholism.

Under deal terms, GSK will give Vesalius Therapeutics $80 million in upfront and equity payments to identify treatments for ...

GSK Plc agreed on a partnership deal worth as much as $650 million with US biotech Vesalius Therapeutics to help advance drug ...

GSK has licensed a small molecule for Parkinson's and is teaming up on additional targets for the disease and another ...

For the first time, researchers at Phoenix's Barrow Neurological Institute have collected and displayed together the ...

Cambridge, USA-based Vesalius Therapeutics has entered into a multi-target strategic alliance with the UK’s GSK to discover ...

Life sciences venture capitalist Vesalius Biocapital has raised 120 million euros in funding, focusing on investment in digital health as well as biotechs. The fund Vesalius Biocapital III was ...

A few individuals, such as Andreas Vesalius, Ambroise Paré and William Harvey, made particularly important contributions to medical knowledge during the 16th and 17th centuries. An illustration ...

Haw, Stephen G. 2023. Nutmeg and the Identity of Chinese Rou doukou. Acta Orientalia Academiae Scientiarum Hungaricae, Vol. 76, Issue. 3, p. 373.